揭开肿瘤疗效终点的方法论之谜：从统计到临床，反之亦然。致编辑的信，内容涉及M. P. Goetz等人撰写的 "Abemaciclib加非甾体类芳香化酶抑制剂作为HR+、HER2-晚期乳腺癌的初始疗法：M.P.Goetz等人撰写的 "Abemaciclib联合非甾体芳香化酶抑制剂作为HR+、HER2-晚期乳腺癌的初始疗法：MONARCH 3的最终总生存率结果 "的编辑来信

{"title":"揭开肿瘤疗效终点的方法论之谜：从统计到临床，反之亦然。致编辑的信，内容涉及M. P. Goetz等人撰写的 \"Abemaciclib加非甾体类芳香化酶抑制剂作为HR+、HER2-晚期乳腺癌的初始疗法：M.P.Goetz等人撰写的 \"Abemaciclib联合非甾体芳香化酶抑制剂作为HR+、HER2-晚期乳腺癌的初始疗法：MONARCH 3的最终总生存率结果 \"的编辑来信","authors":"R De Sanctis, P Bruzzi, A Zambelli","doi":"10.1016/j.annonc.2024.08.2345","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":" ","pages":"1201-1202"},"PeriodicalIF":56.7000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3' by M. P. Goetz et al.\",\"authors\":\"R De Sanctis, P Bruzzi, A Zambelli\",\"doi\":\"10.1016/j.annonc.2024.08.2345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8000,\"journal\":{\"name\":\"Annals of Oncology\",\"volume\":\" \",\"pages\":\"1201-1202\"},\"PeriodicalIF\":56.7000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.annonc.2024.08.2345\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.annonc.2024.08.2345","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}